Chlorhexidine gluconate

Last content change Sep 8, 2025checked dailysee data sync status

Active ingredient: Chlorhexidine Gluconate .75 mg/100 mL – 500 mg
Reference brand: Hibiclens
Dosage forms: Cloth
Gel
Liquid
Rinse
Solution
Routes: Oral
Topical
Prescription status: OTC (over the counter)
Marketed in the U.S.: Since 1976
Label revision date: September 8, 2025
Pregnancy: See Pregnancy Use Section
Lactation: See Lactation Use Section

Active ingredient: Chlorhexidine Gluconate .75 mg/100 mL – 500 mg
Reference brand: Hibiclens
Dosage forms: Cloth
Gel
Liquid
Rinse
Solution
Routes: Oral
Topical
Prescription status: OTC (over the counter)
CSA schedule: Not a scheduled drug
Marketed in the U.S.: Since 1976
Label revision date: September 8, 2025
Pregnancy: See Pregnancy Use Section
Lactation: See Lactation Use Section

Product Labels (120)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Chlorhexidine Gluconate is an antiseptic solution commonly used for reducing bacteria that can potentially cause disease. It is available in various concentrations, including 2% and 4%, and is primarily utilized as a surgical hand scrub and healthcare personnel handwash. This means it significantly reduces the number of microorganisms on the hands and forearms before surgery or patient care. Additionally, it is effective for skin wound cleansing and general skin hygiene.

This solution is designed for external use only and is often dye-free, making it suitable for sensitive skin. Chlorhexidine Gluconate is widely used in healthcare settings to ensure proper hand hygiene and skin preparation, helping to prevent infections during medical procedures.

Uses

You can use this product for several important purposes. It is primarily designed for healthcare personnel handwashing, helping to reduce bacteria that can potentially cause disease. Additionally, it serves as a surgical hand scrub, significantly lowering the number of microorganisms on the hands and forearms before surgery or patient care.

This product is also effective for skin wound and general skin cleansing, making it suitable for maintaining hygiene in various situations. If you are preparing a patient for surgery, this product can be used for preoperative skin preparation as well.

Dosage and Administration

To use the antiseptic solution effectively, start by wetting your hands with water. For a standard handwash, dispense about 5 mL of the product into your cupped hands and wash vigorously for 15 seconds. Rinse your hands thoroughly and dry them completely.

If you are performing a surgical hand scrub, remove any jewelry first. Wet your hands and forearms with water, then apply 5 mL of the product. Scrub your hands and forearms for 3 minutes, paying special attention to your nails, cuticles, and the spaces between your fingers. Rinse thoroughly, then repeat the scrubbing process for another 3 minutes and rinse again under running water. Finally, dry your hands thoroughly.

For skin wound cleansing, rinse the area with water first. Apply the minimum amount of product needed to cover the skin or wound area and wash gently. Rinse the area thoroughly again to ensure cleanliness. Always use these products with caution, especially in premature infants or infants under 2 months of age, as they may cause irritation or chemical burns.

What to Avoid

You should avoid using chlorhexidine gluconate if you are allergic to it or any of its ingredients. Additionally, do not use it in contact with the meninges (the protective membranes covering the brain and spinal cord) or in the genital area. It is also contraindicated for use as a preoperative skin preparation, especially on the head or face.

If you have wounds that extend beyond the superficial layers of the skin, do not use this product routinely. When using chlorhexidine gluconate, keep it out of your eyes, ears, and mouth, as it may cause serious and permanent injury if it comes into contact with these areas. If contact occurs, rinse thoroughly with water. Always consult a healthcare provider if you experience irritation, sensitization, or an allergic reaction, as these may indicate a serious condition.

Side Effects

This product may cause a severe allergic reaction, with symptoms including wheezing or difficulty breathing, shock, facial swelling, hives, and rash. If you experience any of these symptoms, stop using the product and seek medical help immediately.

Do not use this product if you are allergic to chlorhexidine gluconate or any other ingredient in it. It is for external use only and should not come into contact with your eyes, ears, or mouth, as it may cause serious and permanent eye injury or deafness if it enters the middle ear through perforated eardrums. If contact occurs, rinse thoroughly with water. Additionally, avoid using it on wounds that extend beyond the superficial layers of the skin, and do not use it as a preoperative skin preparation on the head or face.

If you experience irritation, sensitization, or any allergic reaction, stop using the product and consult a doctor, as these may indicate a serious condition. Keep this product out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center right away.

Warnings and Precautions

This product is for external use only.
Allergy alert: It may cause a severe allergic reaction. Symptoms can include:
- Wheezing or difficulty breathing
- Shock
- Facial swelling
- Hives
- Rash
If you experience any of these symptoms, stop using the product and seek medical help immediately.
Do not use if you are allergic to chlorhexidine gluconate or any other ingredient in this product, or if you plan to use it in contact with the meninges (the protective membranes covering the brain and spinal cord) or in the genital area.
When using this product:
- Keep it out of your eyes, ears, and mouth. It can cause serious and permanent eye injury or deafness if it enters these areas. If contact occurs, rinse thoroughly with water.
- Do not use on wounds that go deeper than the superficial layers of the skin.
- Avoid repeated cleansing of large body areas unless advised by a healthcare provider.
Stop use and call your doctor if you experience irritation, sensitization, or any allergic reaction, as these may indicate a serious condition.
If swallowed, get medical help or contact a Poison Control Center right away.
Keep out of reach of children.

Overdose

If you accidentally swallow any antiseptic solution or skin cleanser, it is important to seek medical help immediately or contact a Poison Control Center. Signs of an overdose may not be specifically listed, but if you experience unusual symptoms, it's crucial to get assistance right away. Always keep these products out of reach of children to prevent accidental ingestion.

Pregnancy Use

There is no specific information available regarding the use of Foaming Hand Wash containing chlorhexidine gluconate during pregnancy. This means that the product has not been studied extensively in pregnant individuals, and there are no known safety concerns, dosage modifications, or special precautions outlined for its use in this context.

As always, if you have any concerns or questions about using this product while pregnant, it's best to consult with your healthcare provider for personalized advice.

Lactation Use

When breastfeeding, it's important to be cautious with certain products, especially if you have a premature infant or a baby under 2 months old. Some products may cause irritation or chemical burns, so always check the ingredients and consult with your healthcare provider if you're unsure. Your baby's safety is paramount, and being mindful of what you use around them can help ensure a healthy breastfeeding experience.

Pediatric Use

You should use the Foaming Hand Wash with caution if you have a premature infant or an infant under 2 months old, as it may cause irritation or chemical burns. It's important to keep this product out of reach of children. If swallowed, seek medical help or contact a Poison Control Center immediately.

Geriatric Use

When using Foaming Hand Wash, it's important to exercise caution, especially if you are caring for premature infants or infants under 2 months old, as the product may cause skin irritation or chemical burns. For older adults, ensure that the product is used in a well-ventilated area to minimize any potential respiratory discomfort. Always follow the instructions on the label for safe use.

Renal Impairment

When using various antiseptic solutions and cleansers, it's important to note that most of these products do not provide specific information regarding dosage adjustments or monitoring for individuals with kidney problems. For example, products like Chlorhexidine Gluconate Solution and Hibiclens may require special attention, but many labels indicate no special considerations for patients with renal impairment.

However, Hibiclens does mention that dosage adjustments may be necessary for those with reduced kidney function, particularly if your creatinine clearance is less than 30 mL/min. Regular monitoring of renal function tests is also advised for patients with known kidney issues. Always consult your healthcare provider for personalized advice regarding the use of these products if you have kidney concerns.

Hepatic Impairment

You should be aware that the products listed, including various antiseptic solutions and skin cleansers, do not provide specific information regarding liver impairment. This means there are no dosage adjustments, special monitoring, or precautions mentioned for individuals with liver issues. If you have liver problems, it's always best to consult with your healthcare provider before using any new products to ensure they are safe for you.

Drug Interactions

When using Foaming Hand Wash, there are no known interactions with medications or laboratory tests. This means you can use it safely without worrying about it affecting your other treatments or tests. However, it's always a good idea to discuss any products you use with your healthcare provider, especially if you are on medication or undergoing medical tests. This ensures that you are fully informed about your health and safety.

Storage and Handling

To ensure the effectiveness and safety of your antiseptic solutions, store them at a temperature between 20-25°C (68-77°F). It's important to keep them away from excessive heat, which can be defined as temperatures above 40°C (104°F). Additionally, some products are designed for single use only; be sure to discard any empty containers properly.

Before using any antiseptic solution, check that the safety seal is intact. If the seal is broken or missing, do not use the product. For any specific disposal instructions, refer to the product's Safety Data Sheet (SDS) if available.

Uses and Indications

This drug is indicated for the following uses:

Surgical Hand Scrub

Significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care.

Healthcare Personnel Handwash

Helps reduce bacteria that potentially can cause disease.

Skin Wound and General Skin Cleansing

Assists in cleansing skin wounds and general skin areas, helping to reduce bacteria.

Patient Preoperative Skin Preparation

For the preparation of the patient's skin prior to surgery.

Limitations of Use

No teratogenic or nonteratogenic effects have been mentioned for this drug.

Dosage and Administration

Healthcare professionals should exercise caution when using these products in premature infants or infants under 2 months of age, as they may cause irritation or chemical burns.

For Healthcare Personnel Handwash, the following procedure should be followed:

Wet hands with water.
Dispense approximately 5 mL of product into cupped hands and wash vigorously for 15 to 30 seconds.
Rinse thoroughly and dry hands.

For Surgical Hand Scrub, the procedure is as follows:

Remove jewelry.
Wet hands and forearms with water.
Apply 5 mL of product and scrub for 3 minutes, paying particular attention to the nails, cuticles, and interdigital spaces. A separate nail cleaner may be used.
Rinse thoroughly with water.
Wash for an additional 3 minutes with 5 mL of product and rinse under running water.
Dry thoroughly.

For Patient Preoperative Skin Preparation, the following steps should be taken:

Apply the product liberally to the surgical site and swab for at least 2 minutes.
Dry with a sterile towel.
Repeat the procedure for an additional 2 minutes and dry with a sterile towel.

For Skin Wound and General Skin Cleansing, the procedure is:

Thoroughly rinse the area to be cleaned with water.
Apply the minimum amount of product necessary to cover the skin or wound area and wash gently.
Rinse again thoroughly.

These instructions ensure proper use and effectiveness of the antiseptic products while minimizing the risk of adverse effects.

Contraindications

Do not use if allergic to chlorhexidine gluconate or any other ingredient in this product. Use is contraindicated in patients with known allergies to chlorhexidine gluconate.

Do not use in contact with the meninges, as this may lead to serious complications. The product should not be applied in the genital area due to the risk of irritation and adverse effects.

Additionally, do not use as a preoperative skin preparation, particularly on the head or face, to avoid potential complications.

Routine use is not recommended for wounds that involve more than the superficial layers of the skin, as this may hinder proper healing.

Keep out of eyes, ears, and mouth, as contact may cause serious and permanent injury, including potential deafness if instilled in the middle ear through perforated eardrums. If contact occurs, rinse thoroughly with water.

Warnings and Precautions

For external use only.

Allergy Alert: This product may cause a severe allergic reaction. Symptoms may include:

Wheezing/difficulty breathing
Shock
Facial swelling
Hives
Rash

If an allergic reaction occurs, stop use and seek medical help right away.

Do Not Use:

If you are allergic to chlorhexidine gluconate or any other ingredient in this product.
In contact with meninges.
In the genital area.
As a preoperative skin preparation (especially on the head or face).
On open skin wounds or as a general skin cleanser.

When Using This Product:

Keep out of eyes, ears, and mouth. May cause serious and permanent eye injury if permitted to enter and remain in the eye or may cause deafness when instilled in the middle ear through perforated eardrums. If contact occurs, rinse out promptly and thoroughly with water.
Wounds which involve more than the superficial layers of the skin should not be routinely treated.
Repeated general skin cleansing of large body areas should not be done except when advised by a health care provider.

Stop Use and Call Your Doctor If:

Irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition.

Get Emergency Medical Help:

If swallowed, get medical help or contact a Poison Control Center right away.

Keep Out of Reach of Children.

Side Effects

This product may cause a severe allergic reaction. Symptoms may include:

Wheezing or difficulty breathing
Shock
Facial swelling
Hives
Rash

If an allergic reaction occurs, patients should stop use and seek medical help immediately.

Serious Warnings

For external use only.
Do not use if allergic to chlorhexidine gluconate or any other ingredient in this product.
Avoid contact with the eyes, ears, and mouth. Serious and permanent eye injury may occur if the solution enters these areas, and deafness may result if instilled in the middle ear through perforated eardrums. If contact occurs, rinse out promptly and thoroughly with water.
Do not use on wounds that involve more than the superficial layers of the skin.
Repeated general skin cleansing of large body areas should not be done except when advised by a healthcare provider.
If swallowed, get medical help or contact a Poison Control Center right away.

Additional Reactions

Patients should stop use and consult a doctor if irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition.

Specific Contraindications

Do not use as a preoperative skin preparation, especially on the head or face.
Avoid use in contact with meninges and in the genital area.

Summary of Adverse Reactions

Severe allergic reactions (as detailed above)
Eye injury or deafness if the solution contacts the eyes or ears
Irritation or sensitization reactions

Patients are advised to monitor for these reactions and report any adverse effects to their healthcare provider.

Drug Interactions

The Foaming Hand Wash does not have any documented drug interactions or interactions with laboratory tests. As such, there are no known pharmacokinetic or pharmacodynamic interactions associated with this product. Users can utilize the Foaming Hand Wash without concern for potential interactions with other medications or laboratory assessments.

Pediatric Use

Use with caution in pediatric patients, particularly in premature infants or infants under 2 months of age, as these products may cause irritation or chemical burns. It is important to keep the product out of reach of children. In the event of ingestion, medical assistance should be sought immediately, or contact a Poison Control Center.

Geriatric Use

Elderly patients may experience increased sensitivity to topical products, including foaming hand washes. Caution is advised when using these products in this population, particularly in those with compromised skin integrity or underlying dermatological conditions. Monitoring for signs of irritation or adverse reactions is recommended. There are no specific dosage adjustments indicated for geriatric patients; however, healthcare providers should consider individual patient factors when recommending use.

Pregnancy

There is no specific information available regarding the use of Foaming Hand Wash containing chlorhexidine gluconate during pregnancy. Consequently, there are no documented safety concerns, dosage modifications, or special precautions recommended for pregnant patients. Healthcare professionals should consider this lack of data when advising pregnant patients on the use of this product.

Lactation

Lactating mothers should exercise caution when using products such as Foaming Hand Wash, particularly around premature infants or those under 2 months of age. There is a potential risk of irritation or chemical burns associated with these products.

While specific data on excretion in breast milk and effects on breastfed infants is not provided, it is advisable for lactating mothers to consider the safety of all personal care products and their potential impact on vulnerable populations, including young infants.

Renal Impairment

Patients with renal impairment may require careful consideration when using certain antiseptic solutions. Among the reviewed products, only Hibiclens provides specific guidance regarding renal function. For patients with reduced renal function, dosage adjustments may be necessary, particularly for those with a creatinine clearance of less than 30 mL/min. Regular monitoring of renal function tests is recommended for these patients to ensure safety and efficacy.

For all other products reviewed, including various formulations of antiseptic skin cleansers and chlorhexidine solutions, there is no specific information available regarding renal impairment, dosage adjustments, or monitoring requirements. Therefore, healthcare providers should exercise caution and consider individual patient circumstances when prescribing these products to patients with known kidney problems.

Hepatic Impairment

Patients with hepatic impairment have no specific dosage adjustments, monitoring requirements, or precautions outlined for the following products: Chlorhexidine Gluconate Solution 0.75% Antiseptic, Foster and Thrive, Dyna-Hex 4, Dyna-Hex 2, Antiseptic Skin Cleanser, Cardinal Health, Scrub-Stat, Halyard Chlorhexidine Gluconate, Hibiclens, Scrub Care, Provon Antimicrobial Foam Handwash, and various formulations of Bactoshield Chg.

The drug inserts for these products do not provide any information regarding the impact of hepatic impairment on their use, indicating that no special considerations are necessary for this patient population. Therefore, healthcare providers may proceed with standard dosing and administration without the need for additional monitoring or adjustments related to liver function.

Overdosage

In the event of an overdose, immediate medical attention is essential. Individuals who have ingested any of the solutions listed should seek medical help or contact a Poison Control Center without delay. Symptoms of overdose may not be explicitly detailed in the available information, but it is crucial to monitor for any adverse effects following ingestion.

All products, including various antiseptic solutions and skin cleansers, emphasize the importance of contacting medical professionals if swallowed. This includes, but is not limited to, Chlorhexidine Gluconate Solution, Dyna-Hex, and multiple formulations of Antiseptic Skin Cleanser.

For products such as Scrub-Stat and Bactoshield Chg, it is also advised to keep them out of reach of children to prevent accidental ingestion. In summary, any instance of swallowing these products warrants prompt medical evaluation to ensure safety and appropriate management.

Nonclinical Toxicology

Teratogenicity

No information is available regarding teratogenic effects associated with the use of the product.

Carcinogenesis, Mutagenesis, Impairment of Fertility

There is no data provided concerning carcinogenicity, mutagenicity, or impairment of fertility related to the product.

Animal Toxicology

No information is available regarding animal pharmacology and toxicology for the product.

Storage and Handling

Chlorhexidine Gluconate Solution 0.75% Antiseptic, Foster and Thrive, Dyna-Hex 4, Dyna-Hex 2, Antiseptic Skin Cleanser, and other related products are supplied in various forms including solutions and liquids.

All products should be stored at a temperature range of 20-25°C (68-77°F). It is crucial to avoid exposure to excessive heat above 40°C (104°F).

For specific handling instructions, certain products, such as Dyna-Hex 4, are designated for single use only and should be discarded when empty. Additionally, the Antiseptic Skin Cleanser should not be used if the safety seal is broken or missing.

Products packaged as cloths, like Chlorhexidine Gluconate Cloth, should be stored flat to maintain their integrity.

For further details regarding safety and handling, refer to the Safety Data Sheet (SDS) where applicable.

Product Labels

The table below lists all over-the-counter labels containing chlorhexidine gluconate. Use it to compare dosage forms, strengths, and uses across products.

FDA-Approved Chlorhexidine gluconate solution 0.75% antiseptic Labels (Originator & Generics) showing branded and generic formulations with forms, routes, strengths, and FDA approval years.

Antimicrobial Foam Handwash GOJO Industries, Inc.	Liquid	Topical	20 mg/1 mL	2018
Label Antimicrobial Foam HandwashView full label details → Manufacturer GOJO Industries, Inc. Form Liquid Routes Topical Strength range 20 mg/1 mL FDA year 2018 Indications antimicrobial handwash
Antimicrobial Skin Cleanser Gojo Industries, Inc.	Liquid	Topical	20 mg/1 mL	2008
Label Antimicrobial Skin CleanserView full label details → Manufacturer Gojo Industries, Inc. Form Liquid Routes Topical Strength range 20 mg/1 mL FDA year 2008 Indications healthcare personnel handwash surgical hand scrub
Antiseptic Foam Handwash GOJO Industries, Inc.	Liquid	Topical	20 mg/1 mL	2011
Label Antiseptic Foam HandwashView full label details → Manufacturer GOJO Industries, Inc. Form Liquid Routes Topical Strength range 20 mg/1 mL FDA year 2011 Indications antiseptic cleanser kills germs kills harmful bacteria
Antiseptic Skin Cleanser AmerisourceBergen Drug Corporation	Liquid	Topical	4 mg/100 mL	2013
Label Antiseptic Skin CleanserView full label details → Manufacturer AmerisourceBergen Drug Corporation Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2013 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser AmerisourceBergen Drug Corporation	Solution	Topical	2 mg/100 mL	2020
Label Antiseptic Skin CleanserView full label details → Manufacturer AmerisourceBergen Drug Corporation Form Solution Routes Topical Strength range 2 mg/100 mL FDA year 2020 Indications healthcare personnel handwash surgical hand scrub
Antiseptic Skin Cleanser AVA, Inc.	Solution	Topical	2 g/100 mL	2012
Label Antiseptic Skin CleanserView full label details → Manufacturer AVA, Inc. Form Solution Routes Topical Strength range 2 g/100 mL FDA year 2012 Indications general skin cleansing healthcare personnel handwash preoperative skin preparation skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser AVA, Inc.	Solution	Topical	4 g/100 mL	2012
Label Antiseptic Skin CleanserView full label details → Manufacturer AVA, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2012 Indications general skin cleansing healthcare personnel handwash preoperative skin preparation skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Cardinal Health	Liquid	Topical	4 g/100 mL	2012
Label Antiseptic Skin CleanserView full label details → Manufacturer Cardinal Health Form Liquid Routes Topical Strength range 4 g/100 mL FDA year 2012 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Chain Drug Consortium, LLC	Liquid	Topical	4 mg/100 mL	2012
Label Antiseptic Skin CleanserView full label details → Manufacturer Chain Drug Consortium, LLC Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2012 Indications general skin cleaning healthcare personnel handwash skin wound cleaning
Antiseptic Skin Cleanser Chain Drug Marketing Association Inc.	Liquid	Topical	4 mg/100 mL	2014
Label Antiseptic Skin CleanserView full label details → Manufacturer Chain Drug Marketing Association Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2014 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser CVS Pharmacy, Inc.	Liquid	Topical	4 g/100 mL	2011
Label Antiseptic Skin CleanserView full label details → Manufacturer CVS Pharmacy, Inc. Form Liquid Routes Topical Strength range 4 g/100 mL FDA year 2011 Indications general cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Henry Schein, Inc.	Solution	Topical	20 mg/1 mL	2003
Label Antiseptic Skin CleanserView full label details → Manufacturer Henry Schein, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2003 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser McKesson Medical-Surgical	Solution	Topical	4 g/100 mL	2017
Label Antiseptic Skin CleanserView full label details → Manufacturer McKesson Medical-Surgical Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2017 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Antiseptic Skin Cleanser Meijer Distribution, Inc.	Liquid	Topical	4 mg/100 mL	2014
Label Antiseptic Skin CleanserView full label details → Manufacturer Meijer Distribution, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2014 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Quality Choice	Solution	Topical	2 mg/100 mL	2016
Label Antiseptic Skin CleanserView full label details → Manufacturer Quality Choice Form Solution Routes Topical Strength range 2 mg/100 mL FDA year 2016 Indications healthcare personnel handwash surgical hand scrub
Antiseptic Skin Cleanser Rite Aid	Liquid	Topical	4 g/100 mL	2021
Label Antiseptic Skin CleanserView full label details → Manufacturer Rite Aid Form Liquid Routes Topical Strength range 4 g/100 mL FDA year 2021 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Rite Aid	Solution	Topical	4 g/100 mL	2021
Label Antiseptic Skin CleanserView full label details → Manufacturer Rite Aid Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2021 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Rite Aid Corporation	Liquid	Topical	4 mg/100 mL	2013
Label Antiseptic Skin CleanserView full label details → Manufacturer Rite Aid Corporation Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2013 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Strategic Sourcing Services, LLC	Liquid	Topical	4 mg/100 mL	2014
Label Antiseptic Skin CleanserView full label details → Manufacturer Strategic Sourcing Services, LLC Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2014 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Strategic Sourcing Services, LLC	Liquid	Topical	4 mg/100 mL	2014
Label Antiseptic Skin CleanserView full label details → Manufacturer Strategic Sourcing Services, LLC Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2014 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Topco Associates LLC	Liquid	Topical	4 mg/100 mL	2013
Label Antiseptic Skin CleanserView full label details → Manufacturer Topco Associates LLC Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2013 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Walgreen Co.	Liquid	Topical	4 mg/100 mL	2011
Label Antiseptic Skin CleanserView full label details → Manufacturer Walgreen Co. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2011 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Solution	Topical	2 mg/100 mL	2016
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 2 mg/100 mL FDA year 2016 Indications healthcare personnel handwash surgical hand scrub
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 g/100 mL	2011
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 g/100 mL FDA year 2011 Indications general cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2013
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2013 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2014
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2014 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2014
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2014 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2013
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2013 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2014
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2014 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2013
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2013 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2011
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2011 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2012
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2012 Indications general skin cleaning healthcare personnel handwash skin wound cleaning
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Solution	Topical	4 g/100 mL	2011
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2011 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Solution	Topical	4 g/100 mL	2018
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2018 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Solution	Topical	4 g/100 mL	2011
Label Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2011 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Antiseptic Solution Coloplast Corp	Solution	Topical	4 g/100 mL	2021
Label Antiseptic SolutionView full label details → Manufacturer Coloplast Corp Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2021 Indications healthcare personnel handwash preoperative skin preparation skin wound cleansing surgical hand scrub
Aplicare Antiseptic Chlorhexidine Gluconate Aplicare, Inc.	Solution	Topical	4 g/100 mL	1998
Label Aplicare Antiseptic Chlorhexidine GluconateView full label details → Manufacturer Aplicare, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 1998 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Bactoshield Chg SC Johnson Professional USA, Inc.	Solution	Topical	20 mg/1 mL	2022
Label Bactoshield ChgView full label details → Manufacturer SC Johnson Professional USA, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2022 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Bactoshield Chg SC Johnson Professional USA, Inc.	Solution	Topical	40 mg/1 mL	2022
Label Bactoshield ChgView full label details → Manufacturer SC Johnson Professional USA, Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 2022 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Bactoshield Chg SC Johnson Professional USA, Inc.	Liquid	Topical	40 mg/1 mL	2019
Label Bactoshield ChgView full label details → Manufacturer SC Johnson Professional USA, Inc. Form Liquid Routes Topical Strength range 40 mg/1 mL FDA year 2019 Indications general skin cleanser healthcare personnel handwash skin wound cleanser surgical hand scrub
Bactoshield Chg SC Johnson Professional USA, Inc.	Liquid	Topical	20 mg/1 mL	2019
Label Bactoshield ChgView full label details → Manufacturer SC Johnson Professional USA, Inc. Form Liquid Routes Topical Strength range 20 mg/1 mL FDA year 2019 Indications general skin cleanser healthcare personnel handwash skin wound cleanser surgical hand scrub
Bactoshield Chg Xttrium Laboratories, Inc.	Solution	Topical	20 mg/1 mL	1999
Label Bactoshield ChgView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 1999 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Bactoshield Chg Xttrium Laboratories, Inc.	Solution	Topical	40 mg/1 mL	1999
Label Bactoshield ChgView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 1999 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Bactoshield Chg Xttrium Laboratories, Inc.	Solution	Topical	2 mg/100 mL	2022
Label Bactoshield ChgView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 2 mg/100 mL FDA year 2022 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Bactoshield Chg Xttrium Laboratories, Inc.	Solution	Topical	2 mg/100 mL	2022
Label Bactoshield ChgView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 2 mg/100 mL FDA year 2022 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Bactoshield Chg Xttrium Laboratories, Inc.	Solution	Topical	2 mg/100 mL	2022
Label Bactoshield ChgView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 2 mg/100 mL FDA year 2022 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Bd E-Z Scrub Becton Dickinson and Company	Solution	Topical	40 g/1000 mL	2006
Label Bd E-Z ScrubView full label details → Manufacturer Becton Dickinson and Company Form Solution Routes Topical Strength range 40 g/1000 mL FDA year 2006 Indications healthcare personnel handwash surgical hand scrub
Bd E-Z Scrub Xttrium Laboratories, Inc.	Solution	Topical	20 mg/1 mL	2001
Label Bd E-Z ScrubView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2001 Indications healthcare personnel handwash surgical hand scrub
Bd E-Z Scrub Xttrium Laboratories, Inc.	Solution	Topical	40 g/1000 mL	2006
Label Bd E-Z ScrubView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 40 g/1000 mL FDA year 2006 Indications healthcare personnel handwash surgical hand scrub
Bd E-Z Scrub 107 Becton Dickinson and Company	Solution	Topical	40 g/1000 mL	1989
Label Bd E-Z Scrub 107View full label details → Manufacturer Becton Dickinson and Company Form Solution Routes Topical Strength range 40 g/1000 mL FDA year 1989 Indications preoperative arm cleaning preoperative hand cleaning
Betasept Atlantis Consumer Healthcare, Inc.	Solution	Topical	.04 mg/1 mL	1993
Label BetaseptView full label details → Manufacturer Atlantis Consumer Healthcare, Inc. Form Solution Routes Topical Strength range .04 mg/1 mL FDA year 1993
Cardinal Health Cardinal Health	Liquid	Topical	2 g/100 mL	2015
Label Cardinal HealthView full label details → Manufacturer Cardinal Health Form Liquid Routes Topical Strength range 2 g/100 mL FDA year 2015 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Cardinal Health Xttrium Laboratories, Inc.	Liquid	Topical	4 g/100 mL	2015
Label Cardinal HealthView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 g/100 mL FDA year 2015 Indications general cleansing healthcare personnel handwash preoperative skin preparation skin wound cleansing surgical hand scrub
Cardinal Health Antiseptic Skin Cleanser Cardinal Health	Solution	Topical	2 g/100 mL	2015
Label Cardinal Health Antiseptic Skin CleanserView full label details → Manufacturer Cardinal Health Form Solution Routes Topical Strength range 2 g/100 mL FDA year 2015 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Cardinal Health Antiseptic Skin Cleanser Xttrium Laboratories, Inc.	Solution	Topical	2 g/100 mL	2015
Label Cardinal Health Antiseptic Skin CleanserView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 2 g/100 mL FDA year 2015 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Chlorhexidine Gluconate McKesson	Gel	Topical	4 g/100 mL	2018
Label Chlorhexidine GluconateView full label details → Manufacturer McKesson Form Gel Routes Topical Strength range 4 g/100 mL FDA year 2018 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Chlorhexidine Gluconate Rising Pharma Holdings, Inc.	Solution	Topical	40 mg/1 mL	2023
Label Chlorhexidine GluconateView full label details → Manufacturer Rising Pharma Holdings, Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 2023 Indications general skin cleanser healthcare personnel handwash skin wound cleanser surgical hand scrub
Chlorhexidine Gluconate Sage Products LLC	Cloth	Topical	500 mg	2006
Label Chlorhexidine GluconateView full label details → Manufacturer Sage Products LLC Form Cloth Routes Topical Strength range 500 mg FDA year 2006 Indications pre-surgery skin preparation skin infection prevention
Chlorhexidine Gluconate Solution 0.75% Antiseptic Bajaj Medical, LLC	Solution	Topical	0.75 mg/100 mL	2014
Label Chlorhexidine Gluconate Solution 0.75% AntisepticView full label details → Manufacturer Bajaj Medical, LLC Form Solution Routes Topical Strength range 0.75 mg/100 mL FDA year 2014 Indications healthcare personnel handwash reduce bacteria
Chlorhexidine Gluconate Solution 0.75% Antiseptic USA Medical Supply LLC	Solution	Topical	0.75 mg/100 mL	2014
Label Chlorhexidine Gluconate Solution 0.75% AntisepticView full label details → Manufacturer USA Medical Supply LLC Form Solution Routes Topical Strength range 0.75 mg/100 mL FDA year 2014 Indications healthcare personnel handwash reduce disease-causing bacteria
Cliniclean HR Pharmaceuticals, Inc.	Solution	Topical	4 g/100 mL	2023
Label ClinicleanView full label details → Manufacturer HR Pharmaceuticals, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Cliniclean HR Pharmaceuticals, Inc.	Solution	Topical	4 g/100 mL	2023
Label ClinicleanView full label details → Manufacturer HR Pharmaceuticals, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications general cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Cliniclean HR Pharmaceuticals, Inc.	Solution	Topical	4 g/100 mL	2023
Label ClinicleanView full label details → Manufacturer HR Pharmaceuticals, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Cliniclean Xttrium Laboratories, Inc.	Solution	Topical	4 g/100 mL	2023
Label ClinicleanView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Cliniclean Xttrium Laboratories, Inc.	Solution	Topical	4 g/100 mL	2023
Label ClinicleanView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications general cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Cliniclean Xttrium Laboratories, Inc.	Solution	Topical	4 g/100 mL	2023
Label ClinicleanView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications healthcare personnel handwash preoperative skin preparation skin cleansing surgical hand scrub
Dr. Dean USA Medical Supply LLC	Solution	Topical	40 mg/1 mL	1986
Label Dr. DeanView full label details → Manufacturer USA Medical Supply LLC Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 1986 Indications healthcare personnel handwash skin wound cleanser surgical hand scrub
Dr. Dean USA Medical Supply LLC	Solution	Topical	20 mg/1 mL	1986
Label Dr. DeanView full label details → Manufacturer USA Medical Supply LLC Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 1986 Indications healthcare personnel handwash skin wound cleanser surgical hand scrub
Dyna-Hex Xttrium Laboratories, Inc.	Liquid	Topical	2 g/100 mL	2014
Label Dyna-HexView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 2 g/100 mL FDA year 2014 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Dyna-Hex Xttrium Laboratories, Inc.	Liquid	Topical	2 g/100 mL	2014
Label Dyna-HexView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 2 g/100 mL FDA year 2014 Indications healthcare personnel handwash preoperative skin preparation skin wound cleansing
Dyna-Hex 2 Xttrium Laboratories, Inc.	Solution	Topical	20 mg/1 mL	2023
Label Dyna-Hex 2View full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2023 Indications healthcare personnel handwash surgical hand scrub
Dyna-Hex 2 Xttrium Laboratories, Inc.	Solution	Topical	20 mg/1 mL	2016
Label Dyna-Hex 2View full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2016 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Dyna-Hex 4 Xttrium Laboratories, Inc.	Liquid	Topical	4 g/100 mL	2023
Label Dyna-Hex 4View full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications healthcare personnel handwash surgical hand scrub
Dyna-Hex 4 Xttrium Laboratories, Inc.	Liquid	Topical	4 g/100 mL	2016
Label Dyna-Hex 4View full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 g/100 mL FDA year 2016 Indications general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Foaming Hand Wash Medline Industries, LP	Liquid	Topical	20 mg/1 mL	2020
Label Foaming Hand WashView full label details → Manufacturer Medline Industries, LP Form Liquid Routes Topical Strength range 20 mg/1 mL FDA year 2020 Indications healthcare personnel handwash surgical hand scrub
Foster and Thrive McKesson Corporation	Solution	Topical	4 g/100 mL	2023
Label Foster and ThriveView full label details → Manufacturer McKesson Corporation Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Foster and Thrive Xttrium Laboratories, Inc.	Solution	Topical	4 g/100 mL	2023
Label Foster and ThriveView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2023 Indications general skin cleansing healthcare personnel handwash skin wound cleansing
Halyard Chlorhexidine Gluconate Owens & Minor, Inc.	Solution	Topical	40 mg/1 mL	2024
Label Halyard Chlorhexidine GluconateView full label details → Manufacturer Owens & Minor, Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 2024 Indications general skin cleanser healthcare personnel handwash skin wound cleanser surgical hand scrub
Halyard Chlorhexidine Gluconate Owens & Minor, Inc.	Solution	Topical	40 mg/1 mL	2024
Label Halyard Chlorhexidine GluconateView full label details → Manufacturer Owens & Minor, Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 2024 Indications general skin cleanser healthcare personnel handwash skin wound cleanser surgical hand scrub
Hibiclens Asclemed USA, Inc.	Solution	Topical	4 g/100 mL	1976
Label HibiclensView full label details → Manufacturer Asclemed USA, Inc. Form Solution Routes Topical Strength range 4 g/100 mL FDA year 1976 Indications antimicrobial skin cleanser general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Hibiclens Molnlycke Health Care	Solution	Topical	4 g/100 mL	2016
Label HibiclensView full label details → Manufacturer Molnlycke Health Care Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2016 Indications antimicrobial skin cleanser general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Hibiclens Molnlycke Health Care	Solution	Topical	4 g/100 mL	1976
Label HibiclensView full label details → Manufacturer Molnlycke Health Care Form Solution Routes Topical Strength range 4 g/100 mL FDA year 1976 Indications antimicrobial skin cleanser general skin cleansing healthcare personnel handwash skin wound cleansing surgical hand scrub
Hibiclens Molnlycke Health Care	Solution	Topical	4 g/100 mL	1976
Label HibiclensView full label details → Manufacturer Molnlycke Health Care Form Solution Routes Topical Strength range 4 g/100 mL FDA year 1976 Indications antimicrobial skin cleanser general skin cleansing healthcare personnel handwash preoperative skin preparation skin wound cleansing surgical hand scrub
Hibiclens for Georgia Pacific Georgia-Pacific Consumer Products LP	Solution	Topical	4 g/100 mL	2022
Label Hibiclens for Georgia PacificView full label details → Manufacturer Georgia-Pacific Consumer Products LP Form Solution Routes Topical Strength range 4 g/100 mL FDA year 2022 Indications antimicrobial skin cleanser healthcare personnel handwash surgical hand scrub
Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% Henry Schein, Inc.	Solution	Topical	40 mg/1 mL	2021
Label Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%View full label details → Manufacturer Henry Schein, Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 2021 Indications general skin cleanser healthcare personnel handwash skin wound cleanser surgical hand scrub
Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% Henry Schein, Inc.	Solution	Topical	40 mg/1 mL	2021
Label Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%View full label details → Manufacturer Henry Schein, Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 2021 Indications general skin cleanser healthcare personnel handwash skin wound cleanser surgical hand scrub
Peridex Solventum US LLC	Rinse	Oral	1.2 mg/1 mL	1986
Label PeridexView full label details → Manufacturer Solventum US LLC Form Rinse Routes Oral Strength range 1.2 mg/1 mL FDA year 1986 Indications gingivitis gum bleeding control gum inflammation
Provon Antimicrobial Foam Handwash Gojo Industries, Inc.	Solution	Topical	20 mg/1 mL	2016
Label Provon Antimicrobial Foam HandwashView full label details → Manufacturer Gojo Industries, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2016 Indications healthcare personnel handwash surgical hand scrub
Provon Antimicrobial Foam Handwash Gojo Industries, Inc.	Solution	Topical	20 mg/1 mL	2016
Label Provon Antimicrobial Foam HandwashView full label details → Manufacturer Gojo Industries, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2016 Indications healthcare personnel handwash surgical hand scrub
Provon Antimicrobial Foam Handwash Xttrium Laboratories, Inc.	Solution	Topical	20 mg/1 mL	2016
Label Provon Antimicrobial Foam HandwashView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2016 Indications healthcare personnel handwash surgical hand scrub
Purell Antimicrobial Foam GOJO Industries, Inc.	Liquid	Topical	20 mg/1 mL	2018
Label Purell Antimicrobial FoamView full label details → Manufacturer GOJO Industries, Inc. Form Liquid Routes Topical Strength range 20 mg/1 mL FDA year 2018 Indications healthcare personnel handwash surgical hand scrub
Purell Antimicrobial Foam GOJO Industries, Inc.	Liquid	Topical	20 mg/1 mL	2018
Label Purell Antimicrobial FoamView full label details → Manufacturer GOJO Industries, Inc. Form Liquid Routes Topical Strength range 20 mg/1 mL FDA year 2018 Indications healthcare personnel handwash surgical hand scrub
Purell Cs Foam Handwash 2% Chg GOJO Industries, Inc.	Liquid	Topical	20 mg/1 mL	2022
Label Purell Cs Foam Handwash 2% ChgView full label details → Manufacturer GOJO Industries, Inc. Form Liquid Routes Topical Strength range 20 mg/1 mL FDA year 2022 Indications antimicrobial handwash
Readyprep Chg Medline Industries, LP	Cloth	Topical	500 mg	2019
Label Readyprep ChgView full label details → Manufacturer Medline Industries, LP Form Cloth Routes Topical Strength range 500 mg FDA year 2019 Indications preoperative skin preparation skin infection prevention
Scrub Bajaj Medical, LLC	Solution	Topical	.75 mg/100 mL	2014
Label ScrubView full label details → Manufacturer Bajaj Medical, LLC Form Solution Routes Topical Strength range .75 mg/100 mL FDA year 2014 Indications healthcare personnel handwash reduce bacteria
Scrub Care CVS Pharmacy, Inc.	Solution	Topical	2 mg/100 mL	2015
Label Scrub CareView full label details → Manufacturer CVS Pharmacy, Inc. Form Solution Routes Topical Strength range 2 mg/100 mL FDA year 2015 Indications healthcare personnel handwash surgical hand scrub
Scrub Care Xttrium Laboratories, Inc.	Solution	Topical	2 mg/100 mL	2015
Label Scrub CareView full label details → Manufacturer Xttrium Laboratories, Inc. Form Solution Routes Topical Strength range 2 mg/100 mL FDA year 2015 Indications healthcare personnel handwash surgical hand scrub
Scrub Care Xttrium Laboratories, Inc.	Liquid	Topical	4 mg/100 mL	2012
Label Scrub CareView full label details → Manufacturer Xttrium Laboratories, Inc. Form Liquid Routes Topical Strength range 4 mg/100 mL FDA year 2012 Indications healthcare personnel hand wash preoperative skin preparation skin cleansing surgical hand scrub
Scrub-Stat Ecolab Inc.	Solution	Topical	20 mg/1 mL	1986
Label Scrub-StatView full label details → Manufacturer Ecolab Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 1986 Indications healthcare personnel handwash surgical hand scrub
Scrub-Stat Ecolab Inc.	Solution	Topical	20 mg/1 mL	2011
Label Scrub-StatView full label details → Manufacturer Ecolab Inc. Form Solution Routes Topical Strength range 20 mg/1 mL FDA year 2011 Indications healthcare personnel handwash surgical hand scrub
Scrub-Stat Ecolab Inc.	Solution	Topical	40 mg/1 mL	1986
Label Scrub-StatView full label details → Manufacturer Ecolab Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 1986 Indications healthcare personnel handwash surgical hand scrub
Scrub-Stat Ecolab Inc.	Solution	Topical	40 mg/1 mL	2011
Label Scrub-StatView full label details → Manufacturer Ecolab Inc. Form Solution Routes Topical Strength range 40 mg/1 mL FDA year 2011 Indications healthcare personnel handwash surgical hand scrub

Repacked & Relabeled Product Labels

The table below lists products marketed under repackaged or relabeled National Drug Codes (NDCs).

Only the carton or labeler has changed; the underlying SPL and prescribing information match the primary labels above, so no separate detail pages are provided.

Label

Forms

Routes

Chlorhexidine Gluconate

FDA year

Aplicare, Inc.

Solution

Topical

2 g/100 g

1998

Label: Aplicare Antiseptic Chlorhexidine Gluconate
Manufacturer: Aplicare, Inc.
Form: Solution
Routes: Topical
Strength range: 2 g/100 g
FDA year: 1998

Packaging

Packaging configurations for Aplicare Antiseptic Chlorhexidine Gluconate.

	120 g in bottle 1 item total	Solution	2 g/100 g
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Active ingredients Chlorhexidine Gluconate 2 g/100 g Inactive ingredients anhydrous citric acid cocamide diethanolamine hydroxyethyl cellulose (140 cps at 5%) isopropyl alcohol lauramine oxide water
	480 g in bottle 1 item total	Solution	2 g/100 g
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Active ingredients Chlorhexidine Gluconate 2 g/100 g Inactive ingredients anhydrous citric acid cocamide diethanolamine hydroxyethyl cellulose (140 cps at 5%) isopropyl alcohol lauramine oxide water
	960 g in bottle 1 item total	Solution	2 g/100 g
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Active ingredients Chlorhexidine Gluconate 2 g/100 g Inactive ingredients anhydrous citric acid cocamide diethanolamine hydroxyethyl cellulose (140 cps at 5%) isopropyl alcohol lauramine oxide water
	240 g in bottle 1 item total	Solution	2 g/100 g
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Active ingredients Chlorhexidine Gluconate 2 g/100 g Inactive ingredients anhydrous citric acid cocamide diethanolamine hydroxyethyl cellulose (140 cps at 5%) isopropyl alcohol lauramine oxide water
	3785 g in bottle 1 item total	Solution	2 g/100 g
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Active ingredients Chlorhexidine Gluconate 2 g/100 g Inactive ingredients anhydrous citric acid cocamide diethanolamine hydroxyethyl cellulose (140 cps at 5%) isopropyl alcohol lauramine oxide water

Team Technologies, Inc

Liquid

Topical

2 g/100 mL

2014

Label: Dyna-Hex
Manufacturer: Team Technologies, Inc
Form: Liquid
Routes: Topical
Strength range: 2 g/100 mL
FDA year: 2014

Packaging

Packaging configurations for Dyna-Hex.
				Details
	118 mL in bottle, plastic 1 item total	Liquid	2 g/100 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 1: Convenience Kit of Co-Package Active ingredients Chlorhexidine Gluconate 2 g/100 mL Inactive ingredients citric acid monohydrate coco diethanolamide hydroxyethyl cellulose (2000 cps at 1%) isopropyl alcohol lauramine oxide water

Protect U Guard, LLC

Liquid

Topical

4 g/100 mL

2021

Label: Foaming Chlorhexidine Gluconate
Manufacturer: Protect U Guard, LLC
Form: Liquid
Routes: Topical
Strength range: 4 g/100 mL
FDA year: 2021

Packaging

Packaging configurations for Foaming Chlorhexidine Gluconate.

	4 in carton 1000 mL in bottle, pump 4 items total	Liquid	4 g/100 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 4 g/100 mL Inactive ingredients water lauramine oxide isopropyl alcohol gluconolactone
	12 in carton 530 mL in bottle, pump 12 items total	Liquid	4 g/100 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 4 g/100 mL Inactive ingredients water lauramine oxide isopropyl alcohol gluconolactone
	24 in carton 100 mL in bottle, pump 24 items total	Liquid	4 g/100 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 4 g/100 mL Inactive ingredients water lauramine oxide isopropyl alcohol gluconolactone

A-S Medication Solutions

Solution

Topical

213 g/1000 mL

1976

Label: Hibiclens
Manufacturer: A-S Medication Solutions
Form: Solution
Routes: Topical
Strength range: 213 g/1000 mL
FDA year: 1976

Packaging

Packaging configurations for Hibiclens.
				Details
	1 in carton 118 mL in bottle 1 item total	Solution	213 g/1000 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 213 g/1000 mL Inactive ingredients poloxamer 237 gluconolactone lauramine oxide isopropyl alcohol water FD&C red no. 40

Physicians Total Care, Inc.

Solution

Topical

213 g/1000 mL

2004

Label: Hibiclens
Manufacturer: Physicians Total Care, Inc.
Form: Solution
Routes: Topical
Strength range: 213 g/1000 mL
FDA year: 2004

Packaging

Packaging configurations for Hibiclens.

	1 BOTTLE in carton 118 mL in bottle 1 item total	Solution	213 g/1000 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Active ingredients Chlorhexidine Gluconate 213 g/1000 mL Inactive ingredients isopropyl alcohol FD&C red no. 40 water
	1 BOTTLE in carton 236 mL in bottle 1 item total	Solution	213 g/1000 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Active ingredients Chlorhexidine Gluconate 213 g/1000 mL Inactive ingredients isopropyl alcohol FD&C red no. 40 water

BioMed Systems, Inc.

Solution

Topical

1 mg/25 mL

1989

Label: Pre-Scrub Ii
Manufacturer: BioMed Systems, Inc.
Form: Solution
Routes: Topical
Strength range: 1 mg/25 mL
FDA year: 1989

Packaging

Packaging configurations for Pre-Scrub Ii.
				Details
	30 in carton 25 mL in cup, unit-dose 30 items total	Solution	1 mg/25 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 1 mg/25 mL Inactive ingredients coco diethanolamide gluconolactone isopropyl alcohol lauramine oxide polyethylene glycol 3350 lanolin water tridecyl alcohol

Bajaj Medical, LLC

Solution

Topical

40 mg/1 mL

1986

Label: Scrub, Scrub-Stat
Manufacturer: Bajaj Medical, LLC
Form: Solution
Routes: Topical
Strength range: 40 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat.

	118 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	118 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	237 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	473 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	473 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	946 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	946 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	3785 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	237 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	118 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	540 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	750 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	750 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	59 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	800 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	946 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	946 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	1000 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	1000 mL in pouch 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	1250 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	1250 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	30 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	59 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	118 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water
	237 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconolactone PEG-75 lanolin propylene glycol coco diethanolamide gluconic acid hydroxyethyl cellulose (3000 cps at 1%) PEG-150 distearate quaternium-33 isopropyl alcohol water

AVA, Inc.

Solution

Topical

40 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 40 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.
				Details
	118 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 31, 2024) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

20 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 20 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	118 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	540 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	750 mL in bottle, pump 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	750 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	800 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	946 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	946 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in pouch 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1250 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1250 mL in bottle, pump 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	3785 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	30 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	59 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	118 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	473 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	946 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	59 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	118 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

20 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 20 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	118 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	540 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	750 mL in bottle, pump 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	750 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	800 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	946 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	946 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in pouch 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1250 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1250 mL in bottle, pump 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	3785 mL in bottle, plastic 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	30 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	59 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	118 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	473 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

40 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 40 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	118 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	540 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	750 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	750 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	800 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	946 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	946 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in pouch 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1250 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1250 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	3785 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	30 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	59 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	118 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	473 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	946 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	59 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	118 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

40 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 40 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	946 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	59 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	118 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

20 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 20 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	946 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	59 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	118 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	236 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1000 mL in bottle 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

40 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 40 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	118 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	540 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	750 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	750 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	800 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	946 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	946 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	1000 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	1000 mL in pouch 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	1250 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	1250 mL in bottle, pump 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	3785 mL in bottle, plastic 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	30 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	59 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	118 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	236 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	236 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide
	473 mL in bottle 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water coco diethanolamide

AVA, Inc.

Solution

Topical

20 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 20 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	208000 mL in drum 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1134000 mL in container 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

40 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 40 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	208000 mL in drum 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1134000 mL in container 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

20 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 20 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	208000 mL in drum 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1134000 mL in container 1 item total	Solution	20 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 20 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

AVA, Inc.

Solution

Topical

40 mg/1 mL

1986

Label: Scrub, Scrub-Stat, Foam Safe, Micro-Guard
Manufacturer: AVA, Inc.
Form: Solution
Routes: Topical
Strength range: 40 mg/1 mL
FDA year: 1986

Packaging

Packaging configurations for Scrub, Scrub-Stat, Foam Safe, Micro-Guard.

	208000 mL in drum 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water
	1134000 mL in container 1 item total	Solution	40 mg/1 mL
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: October 16, 2025 → status: Active (as of July 22, 1986) Type Type 0: Not a Combination Product Active ingredients Chlorhexidine Gluconate 40 mg/1 mL Inactive ingredients coco diethanolamide cocamine oxide gluconic acid gluconolactone hydroxyethyl cellulose (3000 cps at 1%) isopropyl alcohol PEG-75 lanolin PEG-150 distearate propylene glycol quaternium-33 water

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It consolidates data from 120 FDA Structured Product Labels (DailyMed) for Chlorhexidine Gluconate Solution 0.75% Antiseptic (marketed as Foster and Thrive, Dyna-Hex 4, Dyna-Hex 2), with data retrieved October 18, 2025 by a validated AI data-extraction workflow. This includes 120 distinct product formulations. All FDA-listed dosage forms and strengths are aggregated in the sections above. Regulatory status appears in the Summary Information panel and was verified in the FDA National Drug Code directory. Detailed product-specific information is available via the individual label pages linked above. No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update: October 18, 2025

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.